Atlas Trials

Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma

Clinical trial NCT01711593 · COMPLETED

Trial details

NCT number
NCT01711593
Sponsor
Andrew D. Luster, M.D.,Ph.D.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
AsthmaAllergies
Start date
2013-01-01
Primary completion
2016-09-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.